Energenesis BiomedicalLTD Balance Sheet Health
Financial Health criteria checks 6/6
Energenesis BiomedicalLTD has a total shareholder equity of NT$804.0M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$828.6M and NT$24.6M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$699.20m |
| Equity | NT$803.98m |
| Total liabilities | NT$24.59m |
| Total assets | NT$828.57m |
Financial Position Analysis
Short Term Liabilities: 6657's short term assets (NT$719.4M) exceed its short term liabilities (NT$21.3M).
Long Term Liabilities: 6657's short term assets (NT$719.4M) exceed its long term liabilities (NT$3.2M).
Debt to Equity History and Analysis
Debt Level: 6657 is debt free.
Reducing Debt: 6657 has no debt compared to 5 years ago when its debt to equity ratio was 7.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6657 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6657 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 23% each year.